This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rasmussen, T. B.
Right arrow Articles by Storgaard, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rasmussen, T. B.
Right arrow Articles by Storgaard, T.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, January 2005, p. 356-362, Vol. 43, No. 1
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.1.356-362.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Quantitative Multiplex Assay for Simultaneous Detection and Identification of Indiana and New Jersey Serotypes of Vesicular Stomatitis Virus

Thomas B. Rasmussen,1,2 Åse Uttenthal,1* Jovita Fernández,3 and Torben Storgaard4

Department of Virology, Danish Institute for Food and Veterinary Research, Lindholm, Kalvehave,1 The Royal Veterinary and Agricultural University, Laboratory of Virology, Frederiksberg C,2 Novo Nordisk A/S, Applied Trinomics, Måløv, Denmark,4 Centro de Investigación en Sanidad Animal (CISA-INIA), Valdeolmos, Madrid, Spain3

Received 22 April 2004/ Returned for modification 17 June 2004/ Accepted 3 September 2004


arrow
ABSTRACT
 
In order to establish a rapid and reliable system for the detection of vesicular stomatitis virus (VSV), we developed a quantitative reverse transcription-PCR assay for the detection, quantification, and differentiation of the major serotypes, VSV Indiana and VSV New Jersey, using a closed-tube multiplex format. The detection system is based on the recently invented primer-probe energy transfer (PriProET) system. A region of the gene encoding the RNA-dependent RNA polymerase was amplified by using VSV-specific primers in the presence of two serotype-specific fluorescent probes. By incorporating nucleotide analogues in the primers, both serotypes were amplified with similar efficiencies. The generation of specific amplicons resulted in fluorescent signals for either of the two serotypes, and the specificities of the reactions were confirmed from the melting temperature profiles of the fluorescent probes. The limits of detection were found to be less than 10 50% tissue culture infective doses/ml for both serotypes. The diagnostic value of the new method was tested with clinical materials from experimentally infected pigs, and it is concluded that the method is a powerful tool for the rapid identification of VSV.


arrow
INTRODUCTION
 
Vesicular stomatitis (VS) is a zoonotic vesicular disease caused by a negative-sense single-stranded RNA virus member of the Rhabdoviridae family, genus Vesiculovirus. VS virus (VSV) contains two main serotypes, Indiana-1 (Ind-1) and New Jersey (NJ), and multiple subtypes, including Ind-2 and Ind-3 (13). The infection is limited to the Western Hemisphere, but it has been described in France and South Africa (6). The NJ serotype accounts for more than 80% of the clinical cases reported, and the Ind-1 serotype accounts for the remaining clinical cases in areas of endemicity (13). The Office International des Epizooties classifies VS as a list A disease (9), as the clinical signs in domestic livestock, such as cattle and pigs, are indistinguishable from those of foot-and-mouth disease (FMD) (6). The host spectrum of VSV is wide; cattle, pigs, horses, and numerous other species can be infected, which severely complicates efforts for the eradication of VSV. Even humans can occasionally be infected with VSV (6).

The appearance of typical clinical signs of vesicular disease in domestic livestock should always cause a suspicion of FMD. When clinical samples are negative for FMD virus (FMDV), rapid laboratory tests that reliably identify VSV are of urgent need. The diagnostic tools presently available for the diagnosis of VSV infection include virus isolation (by inoculation of cell cultures) and viral antigen detection (enzyme-linked immunosorbent assay and complement fixation and neutralization tests) (9). Detection of VSV by amplification of viral RNA by reverse transcription-PCR (RT-PCR) has been reported previously (4, 7, 8, 14). These assays are exclusively based on gel-based identification of PCR products and are designed to detect NJ (14), Ind-1 and/or NJ by a heminested assay (4), and Ind-1 and NJ by a multiplex assay (7, 8).

In this study, we developed a quantitative RT-PCR assay for the detection and differentiation of the two main VSV serotypes based on the novel primer-probe energy transfer (PriProET) detection system (5, 12). This fluorescence resonance energy transfer detection system combines probe-based real-time monitoring of PCR amplification with confirmation of probe hybridization from the melting temperature (Tm) curve. The PriProET system uses two primers, one of which is labeled with a donor fluorophore and a fluorescent probe labeled with a reporter fluorophore. The primers are extended during each amplification cycle. The fluorescent probe anneals to the extended reverse primer, which enables energy transfer from the donor to the reporter fluorophore. This allows quantification of the specific amplicon, as the fluorescence emitted from the reporter depends directly on the amount of amplicon formed. A region of the gene encoding the RNA-dependent RNA polymerase (the L gene) was amplified in the presence of two serotype-specific fluorescent probes. Amplification was primed with VSV-specific primers, one of which was labeled with the donor fluorophore 6-carboxyfluorescein (FAM). The two serotype-specific fluorescent probes were labeled with a reporter fluorophore, Texas Red (a serotype Ind-1-specific probe) or cyanine 5 (Cy5; a serotype NJ-specific probe). Generation of amplicons specific for either Ind-1 or NJ caused a fluorescence energy transfer between the fluorophores, and the fluorescent signal was monitored. The specificity of the reaction was further confirmed by the Tm profiles of the fluorescent probes. This quantitative RT-PCR assay was used to determine the amount of VSV RNA in clinical samples from experimentally infected pigs.


arrow
MATERIALS AND METHODS
 
Viruses and clinical samples. VSV laboratory strains of serotypes Ind-1 and NJ grown in primary swine kidney cell cultures were obtained from the virus collection of the Danish Institute for Food and Veterinary Research. The titers were determined to be 107.3 and 108.3 50% tissue culture infective doses (TCID50s)/ml, respectively. For in vivo experimentation, two different groups of three 3-month-old pigs were inoculated intradermally in the coronary band of the right foreleg with either 2 x 105 TCID50s of VSV serotype NJ (Colombia 1964 strain; pigs 1, 2, and 3) or 1 x 106 TCID50s of VSV serotype Ind-1 (Colorado 1942 strain; pigs 4, 5, and 6) grown in BHK-21 cell cultures. One infected animal from each group (pigs 3 and 5) was euthanized at postinoculation day (PID) 4; the other inoculated pigs (pigs 1, 4, and 6) were slaughtered at PID 14. Pig 2 died of causes not related to the VSV infection at PID 2. Nasal swabs and blood samples, which were placed in tubes with EDTA anticoagulant, were collected on PIDs 0, 1, 2, 3, 4, 7, 9, 11, and 14. Vesicles were obtained, if they were available. Tonsil and lymph node tissue samples were collected at necropsy.

Design of primers and probes. VSV-specific primers were designed to target the most conserved regions of the L gene of the VSV genome. Conserved regions suitable as primer targets were selected from alignments of all available VSV sequences downloaded from the GenBank database. Additionally, the areas of interest of the VSV strains used in this study were sequenced. Totally conserved regions were absent, so regions with the fewest sequence differences were selected. In order to achieve equivalent amplification efficiencies, degenerate purine and pyrimidine bases were incorporated into the primers specific for the cDNA synthesized from the very divergent serotypes (3). The nucleotide analogues inosine, N6-methoxy-2,6-diaminopurine (dK), and 6H,8H-3,4-dihydropyrimido[4,5-c] (1,2)oxazin-7-one (dP) were used as alternatives to traditional degenerated positions; inosine was incorporated in the primer at a position where the sequence could be one of the four nucleotides, dK was incorporated at a position where the sequence could be either A or G, and dP was incorporated at a position where the sequence could be either C or T. For use in the PriProET PCR, the forward primer was covalently modified with a donor fluorophore (FAM) at the 5' end.

Two differently labeled fluorogenic probes that would hybridize to the VSV sequence between the sequences of the VSV-specific primers were designed. The specific fluorogenic probes were included in the assay to allow real-time detection of the 120-bp specific amplicon and simultaneous differentiation between serotypes Ind-1 and NJ. One specific probe (the Ind-1-specific probe), which has a covalently linked fluorescent reporter dye, Texas Red, attached to the 3'end, would hybridize to amplicons derived from serotype Ind-1 with a specific Tm of 67.1°C. Another specific probe (the NJ-specific probe) with a covalently linked fluorescent reporter dye, Cy5, attached to the 3' end would hybridize to the amplicon derived from serotype NJ with a specific Tm of 67.7°C. The probes would hybridize to the amplicons in a sequence-specific manner, depending on the template present in the sample, and generate a fluorescent signal due to the close proximity of the donor to the reporter fluorophore. These signals could be distinguished on the basis of the corresponding emission spectra (Texas Red, 610 nm; Cy5, 660 nm). The sequences of the primers and probes are listed in Table 1.


View this table:
[in this window]
[in a new window]
  		TABLE 1. Oligonucleotide sequences of primers and probes

RNA extraction, cDNA synthesis, and PriProET PCR protocol. Viral RNA was extracted from infected cell cultures or clinical samples by using an adaptation of the silica-based method (17), and purified total RNA was reverse transcribed into cDNA by using random primers, as described previously (12). Briefly, the 30-µl reaction mixtures contained 16 µl of RNA, 3 µl of 10x RT-PCR buffer (500 mM KCl, 100 mM Tris-HCl [pH 8.3)], 2 mM MgCl2, 0.5 mM deoxynucleoside triphosphates, 1.5 µl of RNase inhibitor, 1.5 µl of Moloney murine leukemia virus reverse transcriptase (Ambion, Austin, Tex.), and 5 µM random nonamers (New England Biolabs, Beverly, Mass.). The samples were incubated for 45 min at 45°C, and the enzyme was subsequently heat inactivated for 10 min at 90°C. The PriProET PCR protocol was performed essentially as described previously (12) with 2 µl of cDNA in each reaction mixture. All PriProET PCRs were cycled with an ABI Prism 7700 sequence detection system (Applied Biosystems) under the following conditions: 95°C for 2 min and 55 cycles of 95°C for 15 s, 60°C for 15 s, and 75°C for 15 s. This was immediately followed by Tm analysis: 95°C for 15 s and 70 cycles of 20°C for 10 s with increments of 1°C/cycle. Fluorescence data were collected during the annealing step (60°C) of each PCR cycle and during the entire Tm analysis. Analysis of the data resulted in the assignation of a threshold cycle (CT) and a Tm to each sample with a positive PCR result. The CT was determined in the exponential phase of the PCR and was defined as the cycle at which the fluorescence exceeded the baseline fluorescence set during the first 5 to 15 cycles. The fluorescence data were analyzed with a spreadsheet program (Microsoft Excel) in a data sheet preprogrammed in-house. Real-time PCR amplification efficiencies (E) were calculated by the equation E = 10–1/slope (11). The relative quantity of virus (the viral load) in the clinical samples was expressed as arbitrary values, defined as 50 minus the observed CT.


arrow
RESULTS
 
Selection of optimal target region for VSV detection. A region with limited genetic variability among the VSV serotypes was located in the L gene and spanned nucleotides 7017 to 7131 (numbered relative to the sequence with GenBank accession number J02428) (16). To establish a PriProET assay for VSV, a single primer pair and two serotype-specific fluorescent probes were designed (Fig. 1; Table 1). The primer pair was designed to amplify all the serotypes represented (VSV-specific primers) by the introduction of degenerate positions in the primer sequences. Instead of traditional degenerate positions, the pyrimidine analogue dP was used to mimic a C or a T residue, the purine analogue dK was used to mimic an A or a G residue, and inosine was used to mimic all four nucleotides. The two serotype-specific probes were designed to target the same area in the amplicon in order to have competition for binding, which favors hybridization of the probe with the highest degree of similarity to the viral target sequence.



View larger version (25K):
[in this window]
[in a new window]
  		FIG. 1. Nucleotide sequence alignment of a part of the VSV L gene corresponding to nucleotides 7017 to 7131, numbered relative to the sequence with GenBank accession number J02428. The alignment represents all the different L-gene sequences from GenBank as of February 2004. GenBank accession numbers are as indicted for the following Ind-1 strains: Mudd Summers, K0237 and J02428 (16); 98COE, AF483864 (15); 85CLB, AF473865 (15); and 94GUB, AF473866 (15). GenBank accession numbers are as indicted for the following NJ strains: Hazelhurst, AY074803 and AY102918; Hazelhurst_a, M20166 (2); and Ogden, M29788 (1). Additionally, the four different VSV strains used in this study were sequenced, and their sequences were added to the alignment. The nucleotide sequence alignment was used to design the primers and probes. The framed sequences correspond to the target regions for the VSV-specific forward primer (5' labeled with FAM), the VSV-specific reverse primer, and the two serotype-specific probes (the Ind-1-specific probe 3' labeled with Texas Red and the NJ-specific probe 3' labeled with Cy5).

Optimization of VSV PriProET assay. Optimization of the VSV PriProET assay was performed in two steps. First, the performances of the VSV-specific primers that were designed were optimized in a real-time SYBR Green format. This allowed optimization of the PCR conditions, such as the annealing temperature and the magnesium concentration, for the forward and the reverse primers. An annealing temperature of 60°C and a magnesium concentration of 3.5 mM were found to be optimal for homogeneous amplification of both serotypes. Second, the optimal correlation between the primers and the probe was optimized by checkerboard titration. Double the amount of the forward primer with respect to the amount of the reverse primer significantly increased the intensity of the fluorescence energy transfer signal; thus, 600 nM forward primer and 300 nM reverse primer were selected. The probe concentrations had less of an influence on the fluorescence signal, and a concentration of 500 nM each probe was selected.

Multiplex detection of VSV. The ability of the PriProET assay to detect VSV in a multiplex format was assessed with virus grown in primary swine kidney cell cultures. Serotype Ind-1 or serotype NJ in Eagle's medium was subjected to RT-PCR with the VSV-specific primers that were designed, with the serotype-specific probes, and by the optimized PriProET RT-PCR protocol. The sensitivity, detection limit, and intra-assay variability of the PriProET assay were determined for each target by testing three replicates of 10-fold dilutions of cell culture-grown VSV serotypes Ind-1 and NJ. The standard curves obtained (Fig. 2E and F) displayed a linear relationship between the log amount of viral nucleic acids in the reaction mixtures and the observed CT, with calculated E values of 1.82 for serotype Ind-1 and 1.88 for serotype NJ. The average between-run correlation coefficients were 0.99 for both standard curves. The limits of detection were repeatedly found to be below 10 TCID50s/ml for both serotypes. The intra-assay variability was ±1 CT value, which corresponds to less than 5% variation between replicates. The interassay variability was evaluated by comparison of the observed CT values for the standards included in each experiment. The interassay variability observed was consistently at the same level as the intra-assay variability (data not shown).



View larger version (25K):
[in this window]
[in a new window]
  		FIG. 2. (A to D) Detection of VSV RNA in cell culture material. Tenfold dilutions of cell culture-grown VSV serotype Ind-1, serotype NJ, and mixtures with each serotype were subjected to RNA extraction, cDNA synthesis, and, subsequently, PriProET PCR. In the mixed dilutions the concentration of Ind-1 was 10 times lower than the concentration of NJ. Each panel (A to D) displays the readout from the multiplex PriProET PCR, with the fluorescent signals from the Ind-specific probe (diamonds; Texas Red; 610 nm) and the NJ-specific probe (crosses; Cy5; 660 nm) indicated. For simplification, the results for only one sample are displayed in each amplification plot. (A) Sample positive for Ind-1 with a CT of 36; (B) sample positive for NJ with a CT of 33; (C) sample positive for Ind-1 with a CT of 36 and positive for NJ with a CT of 33; (D) sample negative for both serotypes. (E and F) Standard curves generated by analysis of 10-fold dilutions of VSV Ind-1 (E) and VSV NJ (F) from cell culture with known numbers of TCID50s per milliliter. Each dilution was analyzed in triplicate. The CT values plotted were obtained from amplification plots similar to those shown in panels A to D. Real-time PCR amplification efficiencies were calculated by the equation E = 10–1/slope (11). The intra-assay variability was ±1 CT, which corresponds to less than 5% variation between replicates.

Simultaneous multiplex detection and differentiation of both serotypes in the same tube was demonstrated by using cDNA derived from a mix of VSV serotypes Ind-1 and NJ. The observed CT values (Fig. 2C) were compared to the CT values for samples with either VSV Ind-1 (Fig. 2A) or VSV NJ (Fig. 2B). As shown in Fig. 2A, a specific signal for serotype Ind-1 was obtained in the Texas Red channel when the VSV Ind-1-containing sample was analyzed. Furthermore, a specific signal for serotype NJ was observed in the Cy5 channel when the VSV NJ-containing sample was analyzed (Fig. 2B). When mixed cDNA was used as the template, a specific signal in each channel was observed in same tube (Fig. 2C). This simultaneous multiplex detection of both serotypes in the same tube displayed CT values equivalent to those for the reactions with only one of the serotypes (Fig. 2A to C). Samples free of VSV RNA were negative (Fig. 2D).

Confirmation of assay specificity and robustness. The specificities of the reactions shown in Fig. 2 were confirmed by the fluorescent probe Tm profiles (Fig. 3A to D). The serotype Ind-1-positive reactions showed a specific Tm of 67.1°C (Fig. 3A), and the serotype NJ-positive reactions showed a specific Tm of 67.7°C (Fig. 3B). Double-positive reactions showed specific Tm peaks in both the Texas Red and the Cy5 channels (Fig. 3C). Specific Tms were absent from all negative reactions (Fig. 3D). The specificity of the assay was further evaluated by testing the cross-reactivity to viruses causing diseases with clinical symptoms similar to those caused by VSV. Purified RNA obtained from cell culture-propagated high-titer viral preparations of FMDV and swine vesicular disease virus was reverse transcribed and used as the template for the VSV PriProET assay. Positive amplifications and specific Tms were absent from these reactions (data not shown).



View larger version (19K):
[in this window]
[in a new window]
  		FIG. 3. (A to D) Confirmation of specificity of amplification of VSV RNA. Each panel displays the readout (–dF/dT) from the fluorescent probe Tm profile analysis, with the fluorescent signals from the serotype Ind-1-specific probe (solid lines) and the serotype NJ-specific probe (dotted lines) indicated. (A) Sample positive for Ind-1; (B) sample positive for NJ; (C) sample positive for both Ind-1 and NJ; (D) sample negative for both serotypes. (E) Cross-detection of VSV serotypes. The diagram displays the readout (–dF/dT) from the fluorescent probe Tm profiles when only one of the two serotype-specific probes was included in the PriProET assay. Observe the larger temperature range in panel E compared to those in panels A to D; the Tm is shifted approximately 25 to 26°C. Serotype Ind-1 was cross-detected in the Tm profile with a Tm of 41.1°C (dotted line) when only the serotype NJ-specific probe was included in the assay. Likewise, serotype NJ was identified in reaction mixtures in which only the serotype Ind-specific probe was included (solid line; Tm = 42.9°C).

The ability of the method to detect potential new emerging strains of VSV with mutations in the probe region not present in the nucleotide alignment of known VSV sequences (Fig. 1) was demonstrated by amplifying VSV serotype Ind-1 without the serotype Ind-1-specific probe. As expected, the amplification plots for these reactions were negative, since the serotype NJ-specific probe does not hybridize to the Ind-1 target sequence at 60°C (the annealing temperature). However, hybridization was revealed by a positive melting profile with a Tm of 41.1°C. Serotype NJ was likewise identified by the Ind-1-specific probe in reaction mixtures from which the NJ-specific probe was excluded. A specific Tm of 42.9°C was observed in these reactions (Fig. 3E).

Detection of acute infections. The ability of the PriProET assay to detect VSV during acute infections was analyzed with experimentally infected pigs. Two groups of three pigs each were inoculated with either VSV serotype Ind-1 or VSV serotype NJ. All pigs had increased rectal temperatures (Fig. 4A and B), and four animals had vesicular lesions. Vesicles were observed in pig 1 at PIDs 7 and 11 and in pig 6 at PID 7. Local vesicular foot lesions at the injection site were observed in pigs 3 and 5 at PID 4. Nasal swab specimens were obtained on PIDs 1 to 4, 7, 9, 11, and 14 and examined by PriProET RT-PCR. VSV nucleic acids were detectable in the swabs at PID 2 for serotype NJ-infected pigs (Fig. 4C) and PID 3 for serotype Ind-1-infected pigs (Fig. 4D). The detection of viral RNA in nasal swab specimens preceded the detection of vesicular lesions. The largest amount of VSV in the nasal swab specimens was observed in pig 1 between PIDs 7 and 11. Similarly, vesicular materials obtained from the diseased pigs were analyzed by the PriProET assay; and selected blood samples and tissues obtained at necropsy, including tonsil and lymph node tissues, were likewise tested for the presence of viral RNA. All the samples obtained from the vesicular lesions contained large amounts of viral RNA. Vesicular materials obtained on PID 4 had CT values of 32 for pig 3 (infected with serotype NJ) and 29 for pig 5 (infected with serotype Ind-1), whereas the CT values for blood obtained from the same pigs were 43 and 47, respectively. The difference in CT values of 11 and 18 corresponds to approximately 103- to 105-fold higher virus contents in vesicles than in blood. Viral RNA was also detected in tonsil and lymph node tissues, but to a lesser extent compared to the amounts detected in vesicular materials.



View larger version (18K):
[in this window]
[in a new window]
  		FIG. 4. (A and B) Rectal temperatures of the group of pigs infected with VSV serotype NJ (A) and VSV serotype Ind-1 (B). Asterisks mark the occurrences of vesicles. (C and D) Detection of viral RNA from serotypes NJ (C) and Ind-1 (D) in nasal swab samples by the multiplex PriProET assay. The viral loads in nasal swabs are displayed as arbitrary units, defined as 50 minus the observed CT value. All nasal swab specimens from NJ-infected animals were negative for Ind-1 by the multiplex PriProET assay, whereas all nasal swabs from Ind-1-infected animals were negative for NJ.


arrow
DISCUSSION
 
VS is an economically very important infectious disease in animals, since it is clinically indistinguishable from the devastating FMD in swine and cattle. It is therefore included in Office International des Epizooties list A, which means that outbreaks of VS must be reported immediately. This situation can cause great economic losses due to trade restrictions. Although VS only affects the Americas, it is crucial to have diagnostic tools that permit a definitive laboratory result in a short time when a vesicular disease is suspected. In order to obtain an early diagnosis and to contain future outbreaks of VS, it will be necessary to implement rapid diagnostic assays.

This report introduces a new real-time multiplex assay that allows the simultaneous detection and differentiation of viral RNA from the two major VSV serotypes, Ind-1 and NJ. We have previously described the PriProET system (12) and have provided details about the real-time detection system with pan-FMDV-specific primers and a pan-FMDV-specific probe. The cycling conditions for the pan-FMDV assay and the multiplex VSV assay are identical, which allows combined side-by-side detection of FMVD and VSV in the same real-time thermocycler. The PriProET assay for VSV described in this paper is a further refinement of the method for multiplex detection and differentiation. So far only a few diagnostic RT-PCR assays for VSV have been reported (4, 7, 8, 14). These are traditional gel-based assays, and none of these are designed for the quantitative detection of VSV. Two of the assays (7, 8) are multiplex assays that detect both VSV serotypes with a combination of serotype-specific primers. To our knowledge a VSV-specific primer set has not been described before, and the high degree of genetic variability in the VSV genomes complicates the design of such primers. Nevertheless, pan-virus-specific primers with sequences conserved between all known serotypes of a virus or even a family of viruses are very attractive for diagnostic purposes, as they result in very robust assays. Pan-virus-specific primers will, for example, allow the detection of genetic recombinants formed between different viral serotypes, and pan-virus-specific primers will likewise be assumed to detect future emerging serotypes of a given virus (5, 10, 12). Despite the extraordinarily high degree of sequence divergence between the two serotypes of VSV, even when the sequence divergence is compared to those of other RNA viruses, we were able to design a VSV-specific primer set in the present study. The primer set covers the very diverse serotypes Ind-1 and NJ, as demonstrated by the experiments performed in this study. Since these serotypes represent the majority of the viruses causing clinical cases of disease (13), it is likely that the primer set will amplify the majority of unknown VSV strains. Whether the primers also amplify serotype Ind-2 or Ind-3 has not been demonstrated due to a lack of nucleotide sequences for these strains. The uniform amplification of serotypes Ind-1 and NJ with equal sensitivities and efficiencies was made possible by the incorporation of nucleotide analogues (inosine, dK, and dP) in the primers. This is consistent with the findings of Hill et al. (3), who found that oligonucleotides containing up to six residues replaced by a mixture of dK and dP primed DNA synthesis efficiently. From a theoretical point of view, the use of multiple dK, dP, and especially inosine residues in the primer sequence results in a less specific hybridization and, as a result, a less specific diagnostic assay. However, this problem was circumvented in the assay described here, in which the specificity of the PCR amplicon was confirmed not only by hybridization of a specific probe but also by precise determination of the Tm for this hybridization. The end result is a unique combination of high specificity and robustness to sequence divergence. The robustness of the VSV assay developed is, however, not restricted to the use of VSV-specific primers. Use of the unique primer-to-probe energy transfer gives a unique robustness to the detection of sequence diversity in the probe region compared to the robustness of other probe-based real-time technologies, such as the TaqMan and molecular beacon detection systems. This robustness of the system was evaluated by testing the ability of the system to detect VSV types with multiple mutations in the probe sequence-specific region, as shown in Fig. 3E. VSV strains with up to 6 nucleotide differences in the probe-specific region could be detected by the Tm profile, although it could not be quantified. If a specific hybridization with a shifted Tm is observed in the Tm profile, the DNA of the amplicon can rapidly be sequenced for precise typing. In cases in which this DNA sequencing reveals completely new variants, cDNA will still be available for rapid PCR amplification and DNA sequencing of other regions of the viral genome. As such, the PriProET system is a powerful tool not only for the detection of viruses that have high mutation rates or that cover very distant genotypes but also as a tool for surveillance for newly emerging viral variants. In the future, we foresee that the unique sequence flexibility of the PriProET system can be extended to cover even whole virus families.

The sensitivity of the novel quantitative multiplex RT-PCR method was shown to be less than 10 TCID50s/ml and to be similar for both principal VSV serotypes when serial dilutions of serotype Ind-1 and NJ viral isolates were used. Nevertheless, to further validate the assay as a diagnostic tool, a collection of clinical samples from pigs experimentally infected with serotype Ind-1 or NJ was tested and the results were compared with those obtained by a previously described gel-based RT-PCR method (8). The results obtained in the present study reflect the qualitative results obtained with the same clinical materials by the gel-based RT-PCR. The multiplex PriProET method allowed relative quantification of the viral load in the clinical material and permitted the detection of VSV in nasal swab specimens at PIDs 2 and 3 for NJ- and Ind-1-infected pigs, respectively, even before the typical vesicular lesions appeared in the affected animals. Furthermore, large amounts of viral RNA were detected in the samples obtained from vesicular lesions. Therefore, whenever vesicles are present, they should be sampled for early diagnosis. A Tm analysis confirmed the specificity of the fluorescence yield for each of the experimental samples. In comparison to the gel-based method, the use of the ABI 7700 system allowed the simultaneous detection and differentiation of both serotypes in a closed-tube format, which represents a less laborious and much faster method. In addition, as the real-time detection format eliminates the need for postamplification handling of the PCR products, the risk of contamination is minimized, and thus, the risk of false-positive reactions is also minimized.

In summary, the results presented here show that the novel PriProET assay can be a powerful diagnostic tool that gives a definitive result in hours from the time of sample receipt and that it can be applied to different clinical materials. We have demonstrated that the use of the present quantitative RT-PCR method provides a sensitive tool for the simultaneous detection and differentiation of the two major VSV serotypes, Ind-1 and NJ. The merging of a fast and robust means of detection, identification, and quantification makes this method a very useful tool for diagnostic laboratories.


arrow
ACKNOWLEDGMENTS
 
Preben Normann is thanked for excellent technical assistance. We are grateful to Nigel Ferris (Institute for Animal Health, Pirbright Laboratory), who provided us with the VSV strains used for the animal experiment.

This study was partly funded by the European Union (Project QLK2-CT-2000-00486).


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Department of Virology, Danish Institute for Food and Veterinary Research, Lindholm, DK-4771 Kalvehave, Denmark. Phone: 45 72 34 79 93. Fax: 45 72 34 79 01. E-mail: aau{at}dfvf.dk. Back


arrow
REFERENCES
 
    1
  1. Barik, S., E. W. Rud, D. Luk, A. K. Banerjee, and C. Y. Kang. 1990. Nucleotide sequence analysis of the L gene of vesicular stomatitis virus (New Jersey serotype): identification of conserved domains in L proteins of nonsegmented negative-strand RNA viruses. Virology 175:332-337.[CrossRef][Medline]
    2. 2
  2. Feldhaus, A. L., and J. A. Lesnaw. 1988. Nucleotide sequence of the L gene of vesicular stomatitis virus (New Jersey): identification of conserved domains in the New Jersey and Indiana L proteins. Virology 163:359-368.[CrossRef][Medline]
    3. 3
  3. Hill, F., D. Loakes, and D. M. Brown. 1998. Polymerase recognition of synthetic oligodeoxyribonucleotides incorporating degenerate pyrimidine and purine bases. Proc. Natl. Acad. Sci. USA 95:4258-4263.[Abstract/Free Full Text]
    4. 4
  4. Hofner, M. C., W. C. Carpenter, N. P. Ferris, R. P. Kitching, and B. F. Ariza. 1994. A hemi-nested PCR assay for the detection and identification of vesicular stomatitis virus nucleic acid. J. Virol. Methods 50:11-20.[CrossRef][Medline]
    5. 5
  5. Ladekjaer-Mikkelsen, A. S., J. Nielsen, T. Stadejek, T. Storgaard, S. Krakowka, J. Ellis, F. McNeilly, G. Allan, and A. Botner. 2002. Reproduction of postweaning multisystemic wasting syndrome (PMWS) in immunostimulated and non-immunostimulated 3-week-old piglets experimentally infected with porcine circovirus type 2 (PCV2). Vet. Microbiol. 89:97-114.[CrossRef][Medline]
    6. 6
  6. Letchworth, G. J., L. L. Rodriguez, and J. D. C. Barrera. 1999. Vesicular stomatitis. Vet. J. 157:239-260.[CrossRef][Medline]
    7. 7
  7. Magnuson, R. J., J. Triantis, L. L. Rodriguez, A. Perkins, C. O. Meredith, B. Beaty, B. McCluskey, and M. Salman. 2003. A single-tube multiplex reverse transcription-polymerase chain reaction for detection and differentiation of vesicular stomatitis Indiana 1 and New Jersey viruses in insects. J. Vet. Diagn. Investig. 15:561-567.[Abstract/Free Full Text]
    8. 8
  8. Nunez, J. I., E. Blanco, T. Hernandez, C. Gomez-Tejedor, M. J. Martin, J. Dopazo, and F. Sobrino. 1998. A RT-PCR assay for the differential diagnosis of vesicular viral diseases of swine. J. Virol. Methods 72:227-235.[CrossRef][Medline]
    9. 9
  9. Office International des Epizooties. 2000. Vesicular stomatitis. In Manual of standards for diagnostic tests and vaccines. Office International des Epizooties, Paris, France. [Online.] http://www.oie.int/.
    10. 10
  10. Oleksiewicz, M. B., A. Botner, K. G. Madsen, and T. Storgaard. 1998. Sensitive detection and typing of porcine reproductive and respiratory syndrome virus by RT-PCR amplification of whole viral genes. Vet. Microbiol. 64:7-22.[CrossRef][Medline]
    11. 11
  11. Pfaffl, M. W. 2001. A new mathematical model for relative quantification in real-time RT- PCR. Nucleic Acids Res. 29:2002-2007.
    12. 12
  12. Rasmussen, T. B., A. Uttenthal, K. de Stricker, S. Belak, and T. Storgaard. 2003. Development of a novel quantitative real-time RT-PCR assay for the simultaneous detection of all serotypes of foot-and-mouth disease virus. Arch. Virol. 148:2005-2021.[CrossRef][Medline]
    13. 13
  13. Rodriguez, L. L. 2002. Emergence and re-emergence of vesicular stomatitis in the United States. Virus Res. 85:211-219.[CrossRef][Medline]
    14. 14
  14. Rodriguez, L. L., G. J. Letchworth, C. F. Spiropoulou, and S. T. Nichol. 1993. Rapid detection of vesicular stomatitis virus New Jersey serotype in clinical samples by using polymerase chain reaction. J. Clin. Microbiol. 31:2016-2020.[Abstract/Free Full Text]
    15. 15
  15. Rodriguez, L. L., S. J. Pauszek, T. A. Bunch, and K. R. Schumann. 2002. Full-length genome analysis of natural isolates of vesicular stomatitis virus (Indiana 1 serotype) from North, Central and South America. J. Gen. Virol. 83:2475-2483.[Abstract/Free Full Text]
    16. 16
  16. Schubert, M., G. G. Harmison, and E. Meier. 1984. Primary structure of the vesicular stomatitis virus polymerase (L) gene: evidence for a high frequency of mutations. J. Virol. 51:505-514.[Abstract/Free Full Text]
    17. 17
  17. Uttenthal, A., T. Storgaard, M. B. Oleksiewicz, and K. de Stricker. 2003. Experimental infection with the Paderborn isolate of classical swine fever virus in 10-week-old pigs: determination of viral replication kinetics by quantitative RT-PCR, virus isolation and antigen ELISA. Vet. Microbiol. 92:197-212.[CrossRef][Medline]

Journal of Clinical Microbiology, January 2005, p. 356-362, Vol. 43, No. 1
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.1.356-362.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Aguilar, H. C., Matreyek, K. A., Filone, C. M., Hashimi, S. T., Levroney, E. L., Negrete, O. A., Bertolotti-Ciarlet, A., Choi, D. Y., McHardy, I., Fulcher, J. A., Su, S. V., Wolf, M. C., Kohatsu, L., Baum, L. G., Lee, B. (2006). N-Glycans on Nipah Virus Fusion Protein Protect against Neutralization but Reduce Membrane Fusion and Viral Entry.. J. Virol. 80: 4878-4889 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rasmussen, T. B.
Right arrow Articles by Storgaard, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rasmussen, T. B.
Right arrow Articles by Storgaard, T.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»